Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C
NCT07777003Phase 1Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Sep 2026
- Primary completion
- May 2027
01
Overview
Phase 1, randomised, double-blind trial in dyslipidemia comparing HS-10582 group with HS-10582 placebo group (2 arms). Primary endpoint: Adverse Events. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
HS-10582
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT07777003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07777003.